TI
NERV icon

Trexquant Investment’s Minerva Neurosciences NERV Stock Holding History

Trexquant Investment’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,561
Closed -$75K – 1358
2020
Q1 		$75K Buy
+1,561
New +$94.2K 0.01% 1051
2018
Q2 		– Sell
-4,145
Closed -$207K – 1102
2018
Q1 		$207K Buy
4,145
+651
+19% +$31.3K 0.01% 938
2017
Q4 		$169K Buy
3,494
+385
+12% +$19.1K 0.02% 967
2017
Q3 		$189K Buy
+3,109
New +$178K 0.05% 656

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Trexquant Investment's NERV Position: Q2 2020 in Review

Trexquant Investment sold out of Minerva Neurosciences (NERV) in Q2 2020, closing a stake of 1,561 shares — an estimated $75K sold.

Trexquant Investment first reported a position in NERV in Q3 2017 and held it in 4 quarters. The position peaked at $207K in Q1 2018. 80 funds tracked by Wall St. Rank hold NERV as of Q2 2020.

  • Trexquant Investment reported no remaining Minerva Neurosciences position as of Q2 2020 after selling out during the quarter.
  • Trexquant Investment sold 1,561 Minerva Neurosciences shares in Q2 2020, an estimated $75K.
  • Trexquant Investment first reported a position in Minerva Neurosciences in Q3 2017 and held it in 4 quarters.
  • Trexquant Investment's Minerva Neurosciences position peaked at $207K in Q1 2018.
  • 80 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2020.

Based on Trexquant Investment's 13F filing for Q2 2020, filed 7 Aug 2020.